发明名称 Quinoxalinediones, process and intermediates for their production, their use and pharmaceutical compositions based on them
摘要 <p>The invention provides compounds of formula (I) and the pharmaceutically acceptable salts thereof, wherein R is a 5-membered ring heteroaryl group containing 3 or 4 nitrogen heteroatoms which is linked to the quinoxalinedione ring by a ring carbon or nitrogen atom, or is a 6-membered ring heteroaryl group containing from 1 to 3 nitrogen heteroatoms which is linked to the quinoxalinedione ring by a ring carbon atom, either of said groups being optionally benzo-fused and optionally substituted, including in the benzo-fused portion, by 1 or 2 substituents; R1 and R2 are each independently selected from H, fluoro, chloro, bromo, C1-C4 alkyl and halo(C1-C4)alkyl; and their pharmaceutically suitable salts; process and intermediates for production of these quinoxalinediones, pharmaceutical compositions based on these compounds and their use.</p>
申请公布号 SK283467(B6) 申请公布日期 2003.08.05
申请号 SK19980001214 申请日期 1997.02.27
申请人 PFIZER RESEARCH AND DEVELOPMENT COMPANY, N. V./S. A. 发明人 BULL DAVID JOHN;CARR CHRISTOPHER LEE;FRAY MICHAEL JONATHAN;GAUTIER ELISABETH COLETTE LOUISE;MOWBRAY CHARLES ERIC;STOBIE ALAN
分类号 A61K31/495;A61K31/498;A61K31/505;A61K31/506;A61K31/535;A61K31/5377;A61P25/00;A61P25/28;A61P43/00;C07D241/44;C07D401/04;C07D401/14;C07D403/04;C07D403/14;C07D409/14;C07D413/14;C07D417/14;C07D521/00;(IPC1-7):C07D401/04 主分类号 A61K31/495
代理机构 代理人
主权项
地址